Bioasis Technologies Inc.

Bioasis Technologies Inc.verified

BIOAF

Price:

$0.0002

Market Cap:

$397.07K

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited ...[Read more]

Industry

Biotechnology

IPO Date

2010-12-31

Stock Exchange

OTC

Ticker

BIOAF

The Enterprise Value as of December 2025 (TTM) for Bioasis Technologies Inc. (BIOAF) is 568.07K

According to Bioasis Technologies Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 568.07K. This represents a change of -96.41% compared to the average of 15.82M of the last 4 quarters.

Bioasis Technologies Inc. (BIOAF) Historical Enterprise Value (quarterly & annually)

How has BIOAF Enterprise Value performed in the past?

The mean historical Enterprise Value of Bioasis Technologies Inc. over the last ten years is 36.31M. The current 568.07K Enterprise Value has changed 56.46% with respect to the historical average. Over the past ten years (40 quarters), BIOAF's Enterprise Value was at its highest in in the August 2016 quarter at 75.37M. The Enterprise Value was at its lowest in in the May 2020 quarter at 10.08M.

Quarterly (TTM)
Annual

Average

36.31M

Median

36.99M

Minimum

14.75M

Maximum

63.26M

Bioasis Technologies Inc. (BIOAF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bioasis Technologies Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 66.94%

Maximum Annual Enterprise Value = 63.26M

Minimum Annual Increase = -35.90%

Minimum Annual Enterprise Value = 14.75M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202219.66M-20.17%
202124.62M66.94%
202014.75M-35.90%
201923.01M-26.70%
201831.39M-26.30%
201742.59M-12.28%
201648.55M-1.66%
201549.37M7.64%
201445.87M-27.49%
201363.26M41.98%

Bioasis Technologies Inc. (BIOAF) Average Enterprise Value

How has BIOAF Enterprise Value performed in the past?

The current Enterprise Value of Bioasis Technologies Inc. (BIOAF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

19.68M

5-year avg

22.69M

10-year avg

36.31M

Bioasis Technologies Inc. (BIOAF) Enterprise Value vs. Peers

How is BIOAF’s Enterprise Value compared to its peers?

Bioasis Technologies Inc.’s Enterprise Value is less than IR Biosciences Holdings Inc. (3.77M), greater than Easy Technologies Inc. (379.10K), less than Todos Medical Ltd. (38.33M), less than enVVeno Medical Corporation (7.12M), less than Regnum Corp. (774.90K), less than GB Sciences, Inc. (2.15M), greater than BioLife Sciences Inc. (311.53K), greater than GlobeStar Therapeutics Corporation (490.12K), less than Banyan Corp. (3.89M), greater than Rimrock Gold Corp. (156.15K),

Build a custom stock screener for Bioasis Technologies Inc. (BIOAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioasis Technologies Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bioasis Technologies Inc. (BIOAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bioasis Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bioasis Technologies Inc.'s Enterprise Value?

What is the highest Enterprise Value for Bioasis Technologies Inc. (BIOAF)?

What is the 3-year average Enterprise Value for Bioasis Technologies Inc. (BIOAF)?

What is the 5-year average Enterprise Value for Bioasis Technologies Inc. (BIOAF)?

How does the current Enterprise Value for Bioasis Technologies Inc. (BIOAF) compare to its historical average?